Doximity is a premium stock of StocksGuide. Please log in to activate an alert for Doximity.
Register for Free
Please register for free to add Doximity to your portfolio.
Doximity Stock News
$43.29
2.24%
NYSE,
Jan 02, 10:10 pm CET
Why the stock moved Beta
StocksGuide Unlimited β full access to AI analyses
With Unlimited you get the full AI functionality for Doximity. π More detailed insights π Exclusive perspectives on opportunities & risks π Clear answers to your questions
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. Β NEW YORK , Dec. 24, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Doximity Inc. (NYSE: DOCS) breached their fiduciary duties to shareholders.
At the start of the new year, investors seeking a fresh approach might consider stocks that are positioned for a reset. Companies trading at or near their lowest level for 2025 could be primed for gains in the new year if conditions are right.
Doximity's Q2 results show record engagement and accelerating adoption of AI workflow tools, signaling deeper physician reliance on the platform. Revenue quality is improving as pharma clients shift from one-off ad buys to longer-term integrated programs. Doximity has a strong Rule-of-50 profile with high margins and $890m cash but no debt.
Doximity, Inc. ( DOCS ) Q2 2026 Earnings Call November 6, 2025 5:00 PM EST Company Participants Perry Gold - Head of Investor Relations Jeffrey Tangney - Co-Founder, CEO & Chairperson Anna Bryson - Chief Financial Officer Conference Call Participants Brian Peterson - Raymond James & Associates, Inc., Research Division Michael Cherny - Leerink Partners LLC, Research Division Allen Lutz - BofA Se...
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 second quarter ended September 30, 2025. βOur platform continues to grow with new AI tools to save physicians' time,β said Jeff Tangney, co-founder and CEO of Doximity. βIn Q2, a record 650,000 prescribers used our workflow tools to...
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Doximity Inc. (NYSE: DOCS) breached their fiduciary duties to shareholders. If you currently own Doximity stock and acquired shares on or before June 24, 2021, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-a...
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter ended September 30, 2025 after market close on November 6, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a liv...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.